Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs

1. PantaleoG

DemarestJF

SoudeynsH

GraziosiC

DenisF

1994 Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370 463 467

2. BorrowP

LewickiH

HahnBH

ShawGM

OldstoneMB

1994 Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68 6103 6110

3. KoupRA

SafritJT

CaoY

AndrewsCA

McLeodG

1994 Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68 4650 4655

4. McMichaelAJ

Rowland-JonesSL

2001 Cellular immune responses to HIV. Nature 410 980 987

5. DeeksSG

WalkerBD

2007 Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27 406 416

6. BettsMR

GrayCM

CoxJH

FerrariG

2006 Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. Expert Rev Vaccines 5 505 516

7. MehlhopE

WhitbyK

OliphantT

MarriA

EngleM

DiamondMS

2005 Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol 79 7466 7477

8. Da CostaXJ

BrockmanMA

AlicotE

MaM

FischerMB

1999 Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S A 96 12708 12712

9. VerschoorA

BrockmanMA

KnipeDM

CarrollMC

2001 Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J Immunol 167 2446 2451

10. KopfM

AbelB

GallimoreA

CarrollM

BachmannMF

2002 Complement component C3 promotes T cell priming and lung migration to control acute influenza virus infection. Nat Med 8 373 378

11. SureshM

MolinaH

SalvatoMS

MastellosD

LambrisJD

SandorM

2003 Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol 170 788 794

12. MehlhopE

DiamondMS

2006 Protective immune responses against West Nile Virus are primed by distinct complement activation pathways. J Exp Med 203 1371 1381

13. StagerS

AlexanderJ

KirbyAC

BottoM

RooijenNV

2003 Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T cell responses. Nat Med 9 1287 1292

14. WilflingsederD

BankiZ

GarciaE

PruensterM

PfisterG

2007 IgG opsonization of HIV impedes provirus formation in and infection of dendritic cells and subsequent long-term transfer to T cells. J Immunol 178 7840 7848

15. StoiberH

SoederholmA

WilflingsederD

GusenbauerS

HildgartnerA

2008 Complement and antibodies: a dangerous liaison in HIV infection? Vaccine 8 I79 185

16. PruensterM

WilflingsederD

BánkiZ

AmmannCG

MuellauerB

2005 C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells. Eur J Immunol 35 2691 2698

17. HasenkrugKJ

DittmerU

2007 Immune control and prevention of chronic Friend retrovirus infection. Front Biosci 12 1544 1551

18. DittmerU

HeH

MesserRJ

SchimmerS

OlbrichAR

OhlenC

GreenbergPD

StromnesIM

IwashiroM

SakaguchiS

EvansLH

PetersonKE

2004 Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20 293 303

19. ZelinskyyG

KraftAR

SchimmerS

ArndtT

DittmerU

2006 Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 36 2658 2670

20. BettsMR

BrenchleyJM

PriceDA

DeRosaSC

DouekDC

2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 65 78

21. AgnelliniP

WolintP

RehrM

CahenzliJ

KarrerU

2007 Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc Natl Acad Sci U S A 104 4565 4570

22. BalkowS

KruxF

LoserK

BeckerJU

GrabbeS

DittmerU

2007 Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells. Blood 110 3949 3958

23. HasenkrugKJ

1999 Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J Virol 73 6468 6473

24. BettsMR

PriceDA

BrenchleyJM

LoréK

GuenagaJ

2004 The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration. J Immunol 172 6407 6417

25. JungS

UnutmazD

WongP

SanoG

De los SantosK

2002 In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17 211 220

26. ProbstHC

van den BroekM

2005 Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 174 3920 3924

27. BrowneEP

LittmanDR

2009 Myd88 is required for an antibody response to retroviral infection. PLoS Pathog 5 e1000298

28. MesserRJ

DittmerU

PetersonKE

HasenkrugKJ

2004 Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. Proc Natl Acad Sci U S A 101(33) 12260 5

29. CastroFV

TuttAL

WhiteAL

TeelingJL

JamesS

2008 CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. Eur J Immunol 38 2263 2273

30. SaronMF

FayolleC

SeboP

LadantD

UllmannA

1997 Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A 94 3314 3319

31. GuermonprezP

KhelefN

BlouinE

RieuP

Ricciardi-CastagnoliP

2001 The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med 193 1035 1044

32. SimsovaM

SeboP

LeclercC

2004 The adenylate cyclase toxin from Bordetella pertussis–a novel promising vehicle for antigen delivery to dendritic cells. Int J Med Microbiol 293 571 576

33. BehrensEM

SriramU

ShiversDK

GallucciM

MaZ

2007 Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J Immunol 178 6268 6279

34. SkoberneM

SomersanS

AlmodovarW

TruongT

PetrovaK

HensonPM

BhardwajN

2006 The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood 108 947 955

35. ThorntonBP

Ve˘tvickaV

RossGD

1994 Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994 Feb 15;152(4) 1727 37

36. LiuF

MboudjekaI

ShenS

ChouTH

WangS

RossTM

LuS

2004 Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine 22 1764 1772

37. OhlénC

KalosM

ChengLE

ShurAC

HongDJ

2002 CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med 195 1407 1418

38. ChenW

QinH

ChesebroB

CheeverMA

1996 Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J Virol 70 7773 7782

39. BánkiZ

KacaniL

RusertP

PruensterM

WilflingsederD

2005 Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS 19 481 486

40. InabaK

InabaM

RomaniN

AyaH

DeguchiM

1992 Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 1693 1702

41. RobertsonMN

MiyazawaM

MoriS

CaugheyB

EvansLH

1991 Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods 34 255 271